Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. LabGenomics Co., Ltd.
  6. Summary
    A084650   KR7084650001

LABGENOMICS CO., LTD.

(A084650)
  Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
32900 32300 31500 29650 29950 Last
3770516 4880169 2451791 2587432 1417395 Volume
-12.03% -1.82% -2.48% -5.87% +1.01% Change
Estimated financial data (e)
Sales 2021 202 B 0,17 B 0,17 B
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022
Net income 2022
Net Debt 2022
P/E ratio 2022
Yield 2022
Capitalization 337 B 286 M 286 M
Capi. / Sales 2021 1,67x
EV / Sales 2022
Nbr of Employees -
Free-Float 85,4%
More Financials
Company
LabGenomics Co., Ltd is a Korea-based company engaged in the provision of in vitro diagnostic (IVD) services. The Company mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The CompanyÔÇÖs IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. It also provides... 
More about the company
All news about LABGENOMICS CO., LTD.
08/28LabGenomics Co., Ltd.'s Equity Buyback announced on May 28, 2021, has expired.
CI
08/04Tranche Update on LabGenomics Co., Ltd.'s Equity Buyback Plan announced on May 28, 2021..
CI
05/28LabGenomics Co., Ltd. authorizes a Buyback Plan.
CI
05/27LabGenomics Co., Ltd. announces an Equity Buyback for 214,132 shares.
CI
04/02LABGENOMICS : Maryland audit faults procurement of 500K virus tests
AQ
2020Optical Biosystems, Inc. announced that it has received $20 million in funding from a g..
CI
2020LABGENOMICS CO., LTD.(KOSDAQ : A084650) added to S&P Global BMI Index
CI
2020LabGenomics Co., Ltd. agreed to acquire 9.09% stake in Calth Corporation for KRW 2 bill..
CI
2020Contextual Genomics Partners with Lab Genomics
CI
2019LabGenomics Co., Ltd's Equity Buyback announced on July 30, 2019, has expired.
CI
2019LabGenomics Co., Ltd. authorizes a Buyback Plan.
CI
2019LabGenomics Co., Ltd. announces an Equity Buyback for 101,419 shares.
CI
2018LabGenomics Co., Ltd. announced that it has received KRW 7 billion in funding from With..
CI
2018LabGenomics Co., Ltd. announced that it expects to receive KRW 7 billion in funding fro..
CI
2017LABGENOMICS CO., LTD.(KOSDAQ : A084650) dropped from S&P Global BMI Index
CI
More news
News in other languages on LABGENOMICS CO., LTD.

- No features available -

More news
Chart LABGENOMICS CO., LTD.
Duration : Period :
LabGenomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABGENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 29 950,00 
Average target price
Spread / Average Target -
Managers and Directors
Seung-Hyun Jin Chief Executive Officer & Director
Yong-Sik Won Director & Head-Operations
Sung-Yong Ahn Independent Director
Taek-Seong Song Auditor
Sector and Competitors